Ever having had preeclampsia was associated with a significantly decreased risk of human epidermal growth factor receptor 2 (HER2)‐enriched breast cancer (HR = 0.33; 95% CI: 0.12–0.91), but there was no association with other intrinsic subtypes (Table 4). Here, ERBB2 is linked to preeclampsia.